BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35583632)

  • 41. The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.
    Bell I; Martin A; Roberts S
    J Virol; 2007 Jun; 81(11):5437-48. PubMed ID: 17360743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
    Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
    Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion.
    Bullock N; Potts J; Simpkin AJ; Koupparis A; Harper SJ; Oxley J; Oltean S
    J Clin Pathol; 2016 Feb; 69(2):171-5. PubMed ID: 26500332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.
    Schenk PW; Stoop H; Bokemeyer C; Mayer F; Stoter G; Oosterhuis JW; Wiemer E; Looijenga LH; Nooter K
    Neoplasia; 2004; 6(4):297-301. PubMed ID: 15256051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
    van Roosmalen W; Le Dévédec SE; Golani O; Smid M; Pulyakhina I; Timmermans AM; Look MP; Zi D; Pont C; de Graauw M; Naffar-Abu-Amara S; Kirsanova C; Rustici G; Hoen PA; Martens JW; Foekens JA; Geiger B; van de Water B
    J Clin Invest; 2015 Apr; 125(4):1648-64. PubMed ID: 25774502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
    Lin JC; Lin CY; Tarn WY; Li FY
    RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40.
    Patel NA; Kaneko S; Apostolatos HS; Bae SS; Watson JE; Davidowitz K; Chappell DS; Birnbaum MJ; Cheng JQ; Cooper DR
    J Biol Chem; 2005 Apr; 280(14):14302-9. PubMed ID: 15684423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SR protein kinase 1 is resilient to inactivation.
    Ngo JC; Gullingsrud J; Giang K; Yeh MJ; Fu XD; Adams JA; McCammon JA; Ghosh G
    Structure; 2007 Jan; 15(1):123-33. PubMed ID: 17223538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.
    Batson J; Toop HD; Redondo C; Babaei-Jadidi R; Chaikuad A; Wearmouth SF; Gibbons B; Allen C; Tallant C; Zhang J; Du C; Hancox JC; Hawtrey T; Da Rocha J; Griffith R; Knapp S; Bates DO; Morris JC
    ACS Chem Biol; 2017 Mar; 12(3):825-832. PubMed ID: 28135068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.
    Eisenreich A; Malz R; Pepke W; Ayral Y; Poller W; Schultheiss HP; Rauch U
    Circ J; 2009 Sep; 73(9):1746-52. PubMed ID: 19597299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer.
    Li Y; Yu S; Wang X; Ye X; He B; Quan M; Gao Y
    J Cell Physiol; 2019 Aug; 234(8):13582-13591. PubMed ID: 30633341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1.
    Belali T; Wodi C; Clark B; Cheung MK; Craig TJ; Wheway G; Wagner N; Wagner KD; Roberts S; Porazinski S; Ladomery M
    Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194642. PubMed ID: 33017668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation of the arginine/serine repeats of lamin B receptor by SRPK1-insights from molecular dynamics simulations.
    Sellis D; Drosou V; Vlachakis D; Voukkalis N; Giannakouros T; Vlassi M
    Biochim Biophys Acta; 2012 Jan; 1820(1):44-55. PubMed ID: 22056509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y; Culmsee C; Klumpp S; Krieglstein J
    Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-posttranscriptional regulations lessen the repressive effect of SRPK1 on brown adipogenesis.
    Lin JC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):503-514. PubMed ID: 29474929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.
    Takamatsu Y; Krähling V; Kolesnikova L; Halwe S; Lier C; Baumeister S; Noda T; Biedenkopf N; Becker S
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival.
    Zhang J; Jiang H; Xia W; Jiang Y; Tan X; Liu P; Jia H; Yang X; Shen G
    Tumour Biol; 2016 Jan; 37(1):283-90. PubMed ID: 26201897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
    Amin EM; Oltean S; Hua J; Gammons MV; Hamdollah-Zadeh M; Welsh GI; Cheung MK; Ni L; Kase S; Rennel ES; Symonds KE; Nowak DG; Royer-Pokora B; Saleem MA; Hagiwara M; Schumacher VA; Harper SJ; Hinton DR; Bates DO; Ladomery MR
    Cancer Cell; 2011 Dec; 20(6):768-80. PubMed ID: 22172722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.